No Heading
Purpose.
The objective was to evaluate amphiphilic scorpion-like macromolecules (AScMs) as drug carriers for hydrophobic drugs.
Methods.
Indomethacin (IMC) was incorporated into two AScM micelles (M12P5 and M12P2) by the O/W emulsion technique. The influences of IMC:polymer feed ratio and molecular weight of the hydrophilic block of AScMs on the micelle size, IMC entrapment efficiency and release behavior were investigated. Furthermore, cytotoxicity of the AScMs was evaluated with human umbilical vein endothelial cells (HUVEC).
Results.
The maximal IMC entrapment efficiency in M12P5 and M12P2 micelles (72.3 and 20.2%, respectively) was obtained at ratios of 0.1 to 1 for indomethacin:polymer. The sizes of IMC-loaded M12P5 and M12P2 polymeric micelles were <20 nm with a narrow size distribution. In vitro release studies revealed that IMC released from M12P5 and M12P2 polymeric micelles showed sustained release behavior during the 24 h of experiment. Additionally, M12P5 and M12P2 polymeric micelles did not induce remarkable cytotoxicity against HUVEC cells at concentrations up to 1 and 0.5 mM, respectively.
Conclusions.
The amphiphilic scorpion-like macromolecules may be useful as novel drug carriers because of their small size, ability to encapsulate hydrophobic drugs and release them in a sustained manner as well as low cytotoxicity.
Similar content being viewed by others
Abbreviations
- AScMs:
-
amphiphilic scorpion-like macromolecules
- DLS:
-
dynamic light scattering
- DMF:
-
N,N-dimethylformamide
- ECGS:
-
endothelial cell growth supplement
- FBS:
-
fetal bovine serum
- HUVEC:
-
human umbilical vein endothelial cells
- IMC:
-
indomethacin
- IMC-M12P5:
-
indomethacin-loaded M12P5 micelles
- IMC-M12P2:
-
indomethacin-loaded M12P2 micelles
- M12P5:
-
poly(ethylene glycol-5000)—mucic acid based amphiphilic scorpion-like macromolecules
- M12P2:
-
poly(ethylene glycol-2000)—mucic acid based amphiphilic scorpion-like macromolecules
- MTT:
-
3-(4,5-dimethyl-thiazol-2-yl)-2,5-diphenyl tetrazolium bromide
- PEG:
-
poly(ethylene glycol)
- PTFE:
-
polytetrafluoroethylene
- TEM:
-
transmission electron microscopy
References
1. S. Y. Kim, I. G. Shin, and Y. M. Lee. Amphiphilic diblock copolymeric nanospheres composed of methoxy poly(ethylene glycol) and glycolide: properties, cytotoxicity and drug release behaviors. Biomaterials 20:1033–1042 (1999).
2. S. Y. Kim and Y. M. Lee. Taxol-loaded block copolymer nanospheres composed of methoxy poly(ethylene glycol) and poly-(caprolactone) as novel anticancer drug carriers. Biomaterials 22:1697–1704 (2001).
3. M. Liu, K. Kono, and J. M. J. Frechet. Water-soluble dendritic unimolecular micelles: their potential as drug delivery agents. J. Control. Rel. 65:121–131 (2000).
4. A. V. Kabanov, E. V. Batrakova, and V. Y. Alakhov. Pluronic block copolymers as novel polymer therapeutics for drug and gene delivery. J. Control. Rel. 82:189–212 (2002).
5. G. Kwon and T. Okano. Polymeric micelles as new drug carriers. Adv. Drug Del. Rev 21:107–116 (1996).
6. K. Kataoka, A. Harada, and Y. Nagasaki. Block copolymer micelles for drug delivery: design, characterization and biological significance. Adv. Drug Del. Rev. 47:113–131 (2001).
7. Y. Kakizawa and K. Kataoka. Block copolymer micelles for delivery of gene and related compounds. Adv. Drug Del. Rev. 54:203–222 (2002).
8. M. Yokoyama, A. Satoh, Y. Sakurai, T. Okano, Y. Matsumura, T. Kakizoe, and K. Kataoka. Incorporation of water-insoluble anti-cancer drug into polymeric micelles and control of their particle size. J. Control. Rel. 55:219–229 (1998).
9. V. P. Torchilin. Structure and design of polymeric surfactant-based drug delivery systems. J. Control. Rel. 23:137–172 (2001).
10. A. Krishnades, I. Rubinstein, and H. Onyuksel. Sterically stabilized phospholipid mixed micelles: in vitro evaluation as a novel carrier for water-insoluble drugs. Pharm. Res. 20:297–302 (2003).
11. R. Gref, M. Luck, P. Quellec, M. Marchand, E. Dellacherie, S. Harnisch, T. Blukn, and R. H. Muller. Stealth corona-core nano-particles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption. Colloids Surf. B. 18:301–313 (2000).
12. M. Tobio, A. Sanchez, A. Vila, I. Soriano, C. Evora, J. L. Vila-Jato, and M. J. Alonso. The role of PEG on the stability in digestive fluids and in vivo fate of PEG-PLA nanoparticles following oral administration. Colloids Surf. B. 18:315–323 (2000).
13. H. Otsuka, Y. Nagasaki, and K. Kataoka. PEGylated nanoparticles for biological and pharmaceutical applications. Adv. Drug Del. Rev. 55:403–419 (2003).
14. F. Kohori, M. Yokoyama, K. Sakai, and T. Okano. Process design for efficient and controlled drug incorporation into polymeric micelle carrier systems. J. Control. Rel. 78:155–163 (2002).
15. W. J. Lin, L. W. Juang, and C. C. Lin. Stability and release performance of a series of Pegylated copolymeric micelles. Pharm. Res. 20:668–673 (2003).
16. L. Tian, L. Yam, N. Zhou, H. Tat, and K. E. Uhrich. Design, synthesis and characterization of amphiphilic scorpion-like macromolecules (AScMs). Macromolecules 37:538–543 (2004).
17. S. C. Lee, C. Kim, I. C. Kwon, H. Chung, and S. Y. Jeong. Polymeric micelles of poly(2-ethyl-2-oxazoline)-block-poly(caprolactone) copolymer as a carrier for paclitaxel. J. Control. Rel. 89:437–446 (2003).
18. G. Fontana, M. Licciardi, S. Mansueto, D. Schillaci, and G. Giammona. Amoxicillin-loaded polyethylcyanoacrylate nanoparticles: influence of PEG coating on the particle size, drug release rate and phagocytic uptake. Biomaterials 22:2857–2865 (2001).
19. Y. S. Nam, H. S. Kang, J. Y. Park, T. G. Park, S. H. Han, and I. S. Chang. New micelle-like polymer aggregates made from PEI-PLGA diblock copolymers: micellar characteristics and cellular uptake. Biomaterials 24:2053–2059 (2003).
20. S. B. La, T. Okano, and K. Kataoka. Preparation and characterization of the micelle-forming polymeric drug indomethacin-incorporated poly(ethylene oxide)-poly(benzyl L-aspartate) block copolymer micelles. J. Pharm. Sci. 85:85–90 (1996).
21. J. Djordjevic, B. Michniak, and K. E. Uhrich. Amphiphilic star-like macromolecules as novel carriers for topical delivery of non-steroidal anti-inflammatory drugs. AAPS PharmSci 5:1–12 (2003).
22. Y. Hu, X. Jiang, Y. Ding, H. Ge, Y. Yuan, and C. Yang. Synthesis and characterization of chitosan-poly(acrylic acid) nanoparticles. Biomaterials 23:3193–3201 (2002).
23. Y. Hu, X. Jiang, Y. Ding, L. Zhang, C. Yang, J. Zhang, J. Chen, and Y. Yang. Preparation and drug release behaviors of nimo-dipine-loaded poly(caprolactone)-poly(ethylene oxide)-polylactide amphiphilic copolymer nanoparticles. Biomaterials 24:2395– 2404 (2003).
24. G. Kwon, M. Naito, M. Yokoyama, T. Okano, Y. Sakurai, and K. Kataoka. Block copolymer micelles for drug delivery: loading and release of doxorubicin. J. Control. Rel. 48:195–201 (1997).
25. H. S. Yoo and T. G. Park. Biodegradable polymeric micelles composed of doxorubicin conjugated PLGA-PEG block copolymer. J. Control. Rel. 70:63–70 (2001).
26. T. Kawauchi, M. Isshiki, M. Taked, and M. Shibayama. Dynamic light scattering studies on poly(vinyl chloride) clusters and aggregates in tetrahydrofuran. Polym. 42:3875–3881 (2001).
27. J. Djordjevic, M. Barch, B. Michniak, K. E. Uhrich. Novel block copolymeric micelles for drug delivery: loading and release of indomethacin. AAPS PharmSci. 5: Abstract W4111 (2003).
28. H. Liu, S. Farrell, and K. E. Uhrich. Drug release characteristics of unimolecular polymeric micelles. J. Control. Rel. 68:167–174 (2000).
29. I. G. Shin, S. Y. Kim, Y. M. Lee, C. S. Cho, and Y. K. Sung. Methoxy poly(ethylene glycol)/caprolactone amphiphilic block co-polymeric micelle containing indomethacin. I. Preparation and characterization. J. Control. Rel. 51:1–11 (1998).
30. Y. Wan, W. Chen, J. Yang, J. Bei, and S. Wang. Biodegradable poly(L-lactide)-poly(ethylene glycol) multiblock copolymer: synthesis and evaluation of cell affinity. Biomaterials 24:2195–2203 (2003).
31. J. Davda and V. Labhasetwar. Characterization of nanoparticle uptake by endothelial cells. Int. J. Pharm. 233:51–59 (2002).
32. Rapoport N. Stabilization and activation of Pluronic micelles for tumor-targeting drug delivery. Colloids Surf. B 16:93–111 (1999).
33. C. Allen, J. Han, Y. Yu, D. Maysinger, and A. Eisenberg. Poly-caprolactone-β-poly(ethylene oxide) copolymer micelles as a delivery vehicle for dihydrotestosterone. J. Control. Rel. 63:275–286 (2000).
34. S. Cammas, T. Matsumoto, T. Okano, Y. Sakurai, and K. Kataoka. Design of functional polymeric micelles as site-specific drug vehicles based on poly(α-hydroxy ethylene oxide-co-β-benzyl L-aspartate) block copolymers. Mater. Sci. Eng. C 4:241– 247 (1997).
35. A. S. Chauhan, S. Sridevi, K. B. Chalasani, A. K. Jain, S. K. Jain, N. K. Jain, and P. V. Diwan. Dendrimer-mediated transdermal delivery: enhanced bioavailability of indomethacin. J. Control. Rel. 90:335–343 (2003).
36. B. G. Yu, T. Okano, K. Kataoka, and G. Kwon. Polymeric micelles for drug delivery: solubilization and haemolytic activity of amphotericin B. J. Control. Rel. 53:131–136 (1998).
37. A. Fini, G. Fazio, and G. Feroci. Solubility and solubilization properties of non-steroidal anti-inflammatory drugs. Int. J. Pharm. 126:95–102 (1995).
38. S. Y. Kim, I. G. Shin, Y. M. Lee, C. S. Cho, and Y. K. Sung. Methoxy poly(ethylene glycol) and caprolactone amphiphilic block copolymeric micelle containing indomethacin. II. Micelle formation and drug release behaviors. J. Control. Rel. 51:13–22 (1998).
39. G. Riess. Micellization of block copolymers. Prog. Polym. Sci. 28:1107–1170 (2003).
40. M. C. Jones and J. C. Leroux. Polymeric micelles- a new generation of colloidal drug carriers. Eur. J. Pharm. Biopharm. 48:101– 111 (1999).
41. C. R. Heald, S. Stolnik, C. D. Matteis, M. C. Garnett, L. Illum, S. S. Davids, and F. A. M. Leermakers. Characterization of poly-(lactic acid):poly(ethyleneoxide) (PLE:PEG) nanoparticles using the self-consistent theory modeling approach. Colloids Surf., A. 212:57–64 (2003).
42. H. R. Ihre, O. L. Padilla De Jesus, F. C. Szoka Jr., and J. M. J. Frechet. Polyester dendritic systems for drug delivery applications: design, synthesis and characterization. Bioconjugate Chem. 13:443–452 (2002).
43. K. Avgoustakis, A. Beletsi, Z. Panagai, P. Klepetsanis, E. Livaniou, G. Evangelatos, and D. S. Ithakissios. Effect of copolymer composition on the physicochemical characteristics, in vitro stability, and biodistribution of PLGA-mPEG nanoparticles. Int. J. Pharm. 259:115–127 (2003).
44. I. S. Kim and S. H. Kim. Development of polymeric nanoparticulate drug delivery systems: evaluation of nanoparticles based on biotinylated poly(ethylene glycol) with sugar moiety. Int. J. Pharm. 257:195–203 (2003).
45. R. Gref, P. Quellec, A. Sanchez, P. Calvo, E. Dellacherie, and M. J. Alonso. Development and characterization of CyA-loaded poly(lactic acid)-poly(ethylene glycol) PEG micro- and nanoparticles. Comparison with conventional PLA particulate carriers. Eur. J. Pharm. Biopharm. 51:111–118 (2001).
46. L. Yang and P. Alexandridis. Physicochemical aspects of drug delivery and release from polymer-based colloids. Curr. Opin. Colloid Interface Sci. 5:132–143 (2000).
47. H. Chakraborty, R. Banerjee, and M. Sarkar. Incorporation of NSAIDs in micelles: implication of structural switchover in drug-membrane interaction. Biophys. Chem. 104:315–325 (2003).
48. G. A. Husseini, G. D. Myrup, W. G. Pitt, D. A. Christensen, and N. Rapoport. Factors affecting acoustically triggered release of drugs from polymeric micelles. J. Control. Rel. 69:43–52 (2000).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Djordjevic, J., Barch, M. & Uhrich, K. Polymeric Micelles Based on Amphiphilic Scorpion-like Macromolecules: Novel Carriers for Water-Insoluble Drugs. Pharm Res 22, 24–32 (2005). https://doi.org/10.1007/s11095-004-9005-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11095-004-9005-3